Treace Medical Concepts, Inc.
TMCI
$5.34
-$0.03-0.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.92M | -501.00K | -15.36M | -21.21M | -18.68M |
| Total Depreciation and Amortization | 2.46M | 1.24M | 2.16M | 2.12M | 1.91M |
| Total Amortization of Deferred Charges | 74.00K | 1.08M | 74.00K | 74.00K | 75.00K |
| Total Other Non-Cash Items | 9.88M | 10.99M | 7.29M | 9.10M | 7.91M |
| Change in Net Operating Assets | 7.70M | -17.01M | -6.00M | -3.98M | 1.56M |
| Cash from Operations | 4.20M | -4.21M | -11.84M | -13.90M | -7.22M |
| Capital Expenditure | -3.54M | -3.07M | -2.86M | -1.73M | -3.93M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.65M | 6.50M | 8.63M | 24.16M | 7.69M |
| Cash from Investing | -1.89M | 3.42M | 5.76M | 22.43M | 3.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 119.00K | 57.00K | 8.00K | 311.00K | 52.00K |
| Repurchase of Common Stock | -401.00K | -31.00K | 0.00 | 0.00 | -237.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -282.00K | 26.00K | 8.00K | 311.00K | -185.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.02M | -760.00K | -6.07M | 8.85M | -3.65M |